Functional characterization of large conductance calcium-activated K+ channel openers in bladder and vascular smooth muscle

  • John Malysz
  • Steven A. Buckner
  • Anthony V. Daza
  • Ivan Milicic
  • Arturo Perez-Medrano
  • Murali Gopalakrishnan
Original Article

Abstract

Calcium activated K+ channels (KCa channels) are found in a variety of smooth muscle tissues, the most characterized of which are the large conductance KCa channels (BKCa or maxi-K+ channels). Recent medicinal chemistry efforts have identified novel BKCa openers including 2-amino-5-(2-fluoro-phenyl)-4-methyl-1H-pyrrole-3-carbonitrile (NS-8), BMS-204352 and its analog 3-(5-chloro-2-hydroxy-phenyl)-3-hydroxy-6-trifluoromethyl-1,3-dihydro-indol-2-one (compound 1), and 5,7-dichloro-4-(5-chloro-2-hydroxy-phenyl)-3-hydroxy-1H-quinolin-2-one (compound 2). Although these compounds are effective BKCa openers as shown by electrophysiological methods, little is known about their effects on smooth muscle contractility. In this study, the responsiveness of structurally diverse BKCa openers—NS-8, compounds 1 and 2 and the well characterized nonselective NS-1619—was assessed using segments of endothelium denuded rat aorta, rat and guinea pig detrusor precontracted with extracellular K+, and Landrace pig detrusor stimulated by electrical field. In all preparations, the compounds tested inhibited or completely abolished contractions with similar potencies (−logIC50 values: 3.8 to 5.1). In rat aorta, in the presence of 80 mM K+, the compounds significantly shifted the concentration-response curve to the right compared with those obtained in 30 mM K+. These data are consistent with K+ channel (BKCa channel) activation as the underlying mechanism of relaxation by compounds that share the electrophysiological property of BKCa current activation. The similar potencies at detrusor and vascular smooth muscle suggest that the achievement of smooth muscle selectivity in vitro with the representative compounds examined in this study may prove to be a challenge when targeting BKCa channels for smooth muscle indications such as overactive bladder.

Keywords

BKCa openers Smooth muscle Bladder Vascular Contractility 

Abbreviations

KCO

Potassium channel opener

BKCa

Large conductance calcium-activated K+ channel

IC50

Molar concentration of test compound for 50% inhibition of response

References

  1. Ahring PK, Strobaek D, Christophersen P, Olesen SP, Johansen TE (1997) Stable expression of the human large-conductance Ca2+-activated K+ channel. FEBS Lett 415:67–70PubMedGoogle Scholar
  2. Becker MN, Brenner R, Atkinson NS (1995) Tissue-specific expression of a Drosophila calcium-activated potassium channel. J Neurosci 15:6250–6259PubMedGoogle Scholar
  3. Bolton TB, Lim SP (1989) Properties of calcium stores and transient outward currents in single smooth muscle cells of rabbit intestine. J Physiol 409:385–401PubMedGoogle Scholar
  4. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW (2000) Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407:870–876PubMedGoogle Scholar
  5. Buckner SA, Oheim KW, Morse PA, Knepper SM, Hancock AA (1996) Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype. Eur J Pharmacol 297:241CrossRefPubMedGoogle Scholar
  6. Buckner SA, Milicic I, Daza A, Davis-Taber R, Scott VE, Sullivan JP, Brioni JD (2000) Pharmacological and molecular analysis of ATP-sensitive K+ channels in the pig and human detrusor. Eur J Pharmacol 400:287–295CrossRefPubMedGoogle Scholar
  7. Buckner SA, Milicic I, Daza AV, Coghlan MJ, Gopalakrishnan M (2002) Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulators. Br J Pharmacol 135:639–648PubMedGoogle Scholar
  8. Butera JA, Antane SA, Hirth B, Lennox JR, Sheldon JH, Norton NW, Warga D, Argentieri TM (2001) Synthesis and potassium channel opening activity of substituted 10H-benzo[4,5]furo[3,2-b]indole-and 5,10-dihydro-indeno[1,2-b]indole-1-carboxylic acids. Bioorg Med Chem Lett 11:2093–2097CrossRefPubMedGoogle Scholar
  9. Chang CP, Dworetzky SI, Wang J, Goldstein ME (1997) Differential expression of the alpha and beta subunits of the large-conductance calcium-activated potassium channel: implication for channel diversity. Brain Res Mol Brain Res 45:33–40CrossRefPubMedGoogle Scholar
  10. Christ GJ, Day NS, Day M, Santizo C, Zhao W, Sclafani T, Zinman J, Hsieh K, Venkateswarlu K, Valcic M, Melman A (2001) Bladder injection of “naked” hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol 281:R1699–R1709PubMedGoogle Scholar
  11. Coghlan MJ, Carroll WA, Gopalakrishnan M (2001) Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 44:1627–1653CrossRefPubMedGoogle Scholar
  12. Dworetzky SI, Trojnacki JT, Gribkoff VK (1994) Cloning and expression of a human large-conductance calcium-activated potassium channel. Brain Res Mol Brain Res 27:189–193PubMedGoogle Scholar
  13. Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, Chang CP, Gribkoff VK (1996) Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci 16:4543–4550PubMedGoogle Scholar
  14. Edwards G, Niederste-Hollenberg A, Schneider J, Noack T, Weston AH (1994) Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol 113:1538–1547PubMedGoogle Scholar
  15. Garcia ML, Giangiacomo KM, Hanner M, Knaus HG, McManus OB, Schmalhofer WA, Kaczorowski GJ (1999) Purification and functional reconstitution of high-conductance calcium activated potassium channel from smooth muscle. Methods Enzymol 294:274–287PubMedGoogle Scholar
  16. Gopalakrishnan M, Buckner SA, Whiteaker KL, Shieh CC, Molinari EJ, Milicic I, Daza AV, Davis-Taber R, Scott VE, Sellers D, Chess-Williams R, Chapple CR, Liu Y, Liu D, Brioni JD, Sullivan JP, Williams M, Carroll WA, Coghlan MJ (2002) (−)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quin olin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization. J Pharmacol Exp Ther 303:379–386CrossRefPubMedGoogle Scholar
  17. Gribkoff VK, Starrett JE Jr, Dworetzky SI (1997) The pharmacology and molecular biology of large-conductance calcium-activated (BK) potassium channels. Adv Pharmacol 37:319–348PubMedGoogle Scholar
  18. Gribkoff VK, Starrett JE Jr, Dworetzky SI (2001a) Maxi-K potassium channels: form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 7:166–177PubMedGoogle Scholar
  19. Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW (2001b) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7:471–477PubMedGoogle Scholar
  20. Heppner TJ, Bonev AD, Nelson MT (1997) Ca2+-activated K+ channels regulate action potential repolarization in urinary bladder smooth muscle. Am J Physiol 273:C110–C117PubMedGoogle Scholar
  21. Herrera GM, Heppner TJ, Nelson MT (2000) Regulation of urinary bladder smooth muscle contractions by ryanodine receptors and BK and SK channels. Am J Physiol Regul Integr Comp Physiol 279:R60–R68PubMedGoogle Scholar
  22. Hewawasam P, Erway M, Moon SL, Knipe J, Weiner H, Boissard CG, Post-Munson DJ, Gao Q, Huang S, Gribkoff VK, Meanwell NA (2002a) Synthesis and structure-activity relationships of 3-aryloxindoles: a new class of calcium-dependent, large conductance potassium (maxi-K) channel openers with neuroprotective properties. J Med Chem 45:1487–1499CrossRefPubMedGoogle Scholar
  23. Hewawasam P, Erway M, Thalody G, Weiner H, Boissard CG, Gribkoff VK, Meanwell NA, Lodge N, Starrett JE Jr (2002b) The synthesis and structure-activity relationships of 1,3-diaryl 1,2,4-(4H)-triazol-5-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel opener targeted for urge urinary incontinence. Bioorg Med Chem Lett 12:1117–1120CrossRefPubMedGoogle Scholar
  24. Hewawasam P, Fan W, Ding M, Flint K, Cook D, Goggins GD, Myers RA, Gribkoff VK, Boissard CG, Dworetzky SI, Starrett JE Jr, Lodge NJ (2003) 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction. J Med Chem 46:2819–2822CrossRefPubMedGoogle Scholar
  25. Holland M, Langton PD, Standen NB, Boyle JP (1996) Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 117:119–129PubMedGoogle Scholar
  26. Hu S, Kim HS (1996) On the mechanism of the differential effects of NS004 and NS1608 in smooth muscle cells from guinea pig bladder. Eur J Pharmacol 318:461–468CrossRefPubMedGoogle Scholar
  27. Huang Y, Lau CW, Ho IH (1997) NS-1619 activates Ca2+-activated K+ currents in rat vas deferens. Eur J Pharmacol 325:21–27CrossRefPubMedGoogle Scholar
  28. Kamb A, Iverson LE, Tanouye MA (1987) Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell 50:405–413PubMedGoogle Scholar
  29. Khan RN, Smith SK, Ashford ML (1998) Contribution of calcium-sensitive potassium channels to NS1619-induced relaxation in human pregnant myometrium. Hum Reprod 13:208–213CrossRefGoogle Scholar
  30. Knot HJ, Standen NB, Nelson MT (1998) Ryanodine receptors regulate arterial diameter and wall [Ca2+] in cerebral arteries of rat via Ca2+-dependent K+ channels. J Physiol 508:211–221PubMedGoogle Scholar
  31. Korovkina VP, Fergus DJ, Holdiman AJ, England SK (2001) Characterization of a novel 132-bp exon of the human maxi-K channel. Am J Physiol Cell Physiol 281:C361–C367PubMedGoogle Scholar
  32. Mackay KB (2001) BMS-204352. Curr Opin Invest Drugs 2:820–823Google Scholar
  33. Ohi Y, Yamamura H, Nagano N, Ohya S, Muraki K, Watanabe M, Imaizumi Y (2001) Local Ca2+ transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol 534:313–326PubMedGoogle Scholar
  34. Patel HJ, Giembycz MA, Keeling JE, Barnes PJ, Belvisi MG (1998) Inhibition of cholinergic neurotransmission in guinea pig trachea by NS1619, a putative activator of large-conductance, calcium-activated potassium channels. J Pharmacol Exp Ther 286:952–958PubMedGoogle Scholar
  35. Pluger S, Faulhaber J, Furstenau M, Lohn M, Waldschutz R, Gollasch M, Haller H, Luft FC, Ehmke H, Pongs O (2000) Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca2+ spark/STOC coupling and elevated blood pressure. Circ Res 87:E53–E60PubMedGoogle Scholar
  36. Sheldon JH, Norton NW, Argentieri TM (1997) Inhibition of guinea pig detrusor contraction by NS-1619 is associated with activation of BKCa and inhibition of calcium currents. J Pharmacol Exp Ther 283:1193–1200PubMedGoogle Scholar
  37. Shieh C, Feng J, Buckner SA, Brioni JD, Coghlan MJ, Sullivan JP, Gopalakrishnan M (2001) Functional implication of spare ATP-sensitive K+ channels in bladder smooth muscle cells. J Pharmacol Exp Ther 296:669–675PubMedGoogle Scholar
  38. Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M (2000a) Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52:557–594PubMedGoogle Scholar
  39. Shieh CC, Scott VE, Hoogenboom L, Coghlan MJ, Sullivan JP, Gopalakrishnan M (2000b) Functional characterization of a cloned calcium-activated potassium channel. Abstract presented at 44th Annual Meeting of Biophysical Society, New Orleans, LA, USA. Biophys J 78:92AGoogle Scholar
  40. Sit SY, Meanwell NA (1998) 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators. Patent WO 9823273Google Scholar
  41. Strobaek D, Christophersen P, Holm NR, Moldt P, Ahring PK, Johansen TE, Olesen SP (1996) Modulation of the Ca2+-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+. Neuropharmacology 35:903–914Google Scholar
  42. Tanaka M, Sasaki Y, Hukui T, Kyotani J, Hayashi S, Hamada K, Kimura Y, Ukai Y, Kitano M, Kimura K (1998) A novel pyrrole derivative, NS-8, activates the Ca2+-sensitive K+-channels and suppresses micturition reflex in rats. Abstract presented at 93rd Annual Meeting of American Urological Association meeting, San Diego, CA, USA. J Urol 159 [Suppl 5]:21Google Scholar
  43. Tanaka M, Sasaki Y, Kimura Y, Fukui T, Hamada K, Ukai Y (2003) A novel pyrrole derivative, NS-8, suppresses the rat micturition reflex by inhibiting afferent pelvic nerve activity. BJU Int 92:1031–1036CrossRefPubMedGoogle Scholar
  44. Turner SC, Carroll WA, White TK, Gopalakrishnan M, Coghlan MJ, Shieh CC, Zhang XF, Parihar AS, Buckner SA, Milicic I, Sullivan JP (2003) The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure-activity relationships of 2-amino-4-azaindoles. Bioorg Med Chem Lett 13:2003–2007CrossRefPubMedGoogle Scholar
  45. Westfall, T, Wibberley, A, McCafferty, G, Sulpizio, A, Hieble JP (2002) BK channel openers can act selectively on the bladder. Abstract presented at International Continence Society Meeting, Heidelberg, Germany, http://www.continet.org/Publications/2002/PDF/491.PDF
  46. Yamamura H, Ohi Y, Muraki K, Watanabe M, Imaizumi Y (2001) BK channel activation by NS-1619 is partially mediated by intracellular Ca2+ release in smooth muscle cells of porcine coronary artery. Br J Pharmacol 132:828–834PubMedGoogle Scholar
  47. Zhang XF, Gopalakrishnan M, Shieh CC (2003) Modulation of action potential firing by iberiotoxin and NS1619 in rat dorsal root ganglion neurons. Neuroscience 122:1003–1011CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • John Malysz
    • 1
  • Steven A. Buckner
    • 1
  • Anthony V. Daza
    • 1
  • Ivan Milicic
    • 1
  • Arturo Perez-Medrano
    • 1
  • Murali Gopalakrishnan
    • 1
  1. 1.Neuroscience ResearchGlobal Pharmaceutical Research and Development, Abbott LaboratoriesAbbott ParkUSA

Personalised recommendations